Workflow
J&J's (JNJ) Q4 Earnings Beat, Darzalex, Stelara Drive Sales
J&JJ&J(US:JNJ) Zacks Investment Research·2024-01-24 01:06

Johnson & Johnson’s (JNJ) fourth-quarter 2023 earnings came in at 2.29pershare,whichbeattheZacksConsensusEstimateof2.29 per share, which beat the Zacks Consensus Estimate of 2.27. Earnings rose 11.7% from the year-ago period.Adjusted earnings exclude intangible amortization and some other special items. Including these items, J&J reported fourth-quarter earnings of 1.70pershare,up39.31.70 per share, up 39.3% from the year-ago quarter.Sales of this drug and medical devices giant came in at 21.4 billion, beating the Zacks Consensus Estimate of $21.1 billion by a slight ma ...